Global Antiandrogens Market Overview:
Global Antiandrogens Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Antiandrogens Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Antiandrogens involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Antiandrogens Market:
The Antiandrogens Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Antiandrogens Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Antiandrogens Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Antiandrogens market has been segmented into:
Genomics
Transcriptomics
Proteomics
Metabolomics
Epigenomics
By Application, Antiandrogens market has been segmented into:
Disease Diagnosis
Drug Discovery
Personalized Medicine
Biomarker Discovery
Toxicology Studies
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Antiandrogens market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Antiandrogens market.
Top Key Players Covered in Antiandrogens market are:
Pacific Biosciencesof California
Inc.
Myriad Genetics
Inc.
BD (Becton
Dickinson and Company)
BioRad Laboratories
Inc.
Oxford Nanopore Technologies
PLC
PerkinElmer
Inc.
Agilent Technologies
Sequenom
Inc.
QIAGEN
Illumina
Inc.
Trimble Inc.
Abbott Laboratories
Thermo Fisher Scientific
HoffmannLa Roche Ltd.
Novogene Co.
Ltd.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Antiandrogens Market Type
4.1 Antiandrogens Market Snapshot and Growth Engine
4.2 Antiandrogens Market Overview
4.3 Genomics
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Genomics: Geographic Segmentation Analysis
4.4 Transcriptomics
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Transcriptomics: Geographic Segmentation Analysis
4.5 Proteomics
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Proteomics: Geographic Segmentation Analysis
4.6 Metabolomics
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.6.3 Metabolomics: Geographic Segmentation Analysis
4.7 Epigenomics
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.7.3 Epigenomics: Geographic Segmentation Analysis
Chapter 5: Antiandrogens Market Application
5.1 Antiandrogens Market Snapshot and Growth Engine
5.2 Antiandrogens Market Overview
5.3 Disease Diagnosis
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Disease Diagnosis: Geographic Segmentation Analysis
5.4 Drug Discovery
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Drug Discovery: Geographic Segmentation Analysis
5.5 Personalized Medicine
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Personalized Medicine: Geographic Segmentation Analysis
5.6 Biomarker Discovery
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 Biomarker Discovery: Geographic Segmentation Analysis
5.7 Toxicology Studies
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.7.3 Toxicology Studies: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Antiandrogens Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 PACIFIC BIOSCIENCESOF CALIFORNIA
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 INC.
6.4 MYRIAD GENETICS
6.5 INC.
6.6 BD (BECTON
6.7 DICKINSON AND COMPANY)
6.8 BIORAD LABORATORIES
6.9 INC.
6.10 OXFORD NANOPORE TECHNOLOGIES
6.11 PLC
6.12 PERKINELMER
6.13 INC.
6.14 AGILENT TECHNOLOGIES
6.15 SEQUENOM
6.16 INC.
6.17 QIAGEN
6.18 ILLUMINA
6.19 INC.
6.20 TRIMBLE INC.
6.21 ABBOTT LABORATORIES
6.22 THERMO FISHER SCIENTIFIC
6.23 HOFFMANNLA ROCHE LTD.
6.24 NOVOGENE CO.
6.25 LTD.
Chapter 7: Global Antiandrogens Market By Region
7.1 Overview
7.2. North America Antiandrogens Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Genomics
7.2.2.2 Transcriptomics
7.2.2.3 Proteomics
7.2.2.4 Metabolomics
7.2.2.5 Epigenomics
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Disease Diagnosis
7.2.3.2 Drug Discovery
7.2.3.3 Personalized Medicine
7.2.3.4 Biomarker Discovery
7.2.3.5 Toxicology Studies
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Antiandrogens Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Genomics
7.3.2.2 Transcriptomics
7.3.2.3 Proteomics
7.3.2.4 Metabolomics
7.3.2.5 Epigenomics
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Disease Diagnosis
7.3.3.2 Drug Discovery
7.3.3.3 Personalized Medicine
7.3.3.4 Biomarker Discovery
7.3.3.5 Toxicology Studies
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Antiandrogens Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Genomics
7.4.2.2 Transcriptomics
7.4.2.3 Proteomics
7.4.2.4 Metabolomics
7.4.2.5 Epigenomics
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Disease Diagnosis
7.4.3.2 Drug Discovery
7.4.3.3 Personalized Medicine
7.4.3.4 Biomarker Discovery
7.4.3.5 Toxicology Studies
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Antiandrogens Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Genomics
7.5.2.2 Transcriptomics
7.5.2.3 Proteomics
7.5.2.4 Metabolomics
7.5.2.5 Epigenomics
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Disease Diagnosis
7.5.3.2 Drug Discovery
7.5.3.3 Personalized Medicine
7.5.3.4 Biomarker Discovery
7.5.3.5 Toxicology Studies
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Antiandrogens Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Genomics
7.6.2.2 Transcriptomics
7.6.2.3 Proteomics
7.6.2.4 Metabolomics
7.6.2.5 Epigenomics
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Disease Diagnosis
7.6.3.2 Drug Discovery
7.6.3.3 Personalized Medicine
7.6.3.4 Biomarker Discovery
7.6.3.5 Toxicology Studies
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Antiandrogens Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Genomics
7.7.2.2 Transcriptomics
7.7.2.3 Proteomics
7.7.2.4 Metabolomics
7.7.2.5 Epigenomics
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Disease Diagnosis
7.7.3.2 Drug Discovery
7.7.3.3 Personalized Medicine
7.7.3.4 Biomarker Discovery
7.7.3.5 Toxicology Studies
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Antiandrogens Scope:
|
Report Data
|
Antiandrogens Market
|
|
Antiandrogens Market Size in 2025
|
USD XX million
|
|
Antiandrogens CAGR 2025 - 2032
|
XX%
|
|
Antiandrogens Base Year
|
2024
|
|
Antiandrogens Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Pacific Biosciencesof California, Inc., Myriad Genetics, Inc., BD (Becton, Dickinson and Company), BioRad Laboratories, Inc., Oxford Nanopore Technologies, PLC, PerkinElmer, Inc., Agilent Technologies, Sequenom, Inc., QIAGEN, Illumina, Inc., Trimble Inc., Abbott Laboratories, Thermo Fisher Scientific, HoffmannLa Roche Ltd., Novogene Co., Ltd..
|
|
Key Segments
|
By Type
Genomics
Transcriptomics
Proteomics
Metabolomics
Epigenomics
By Applications
Disease Diagnosis
Drug Discovery
Personalized Medicine
Biomarker Discovery
Toxicology Studies
|
